Type to search

Samsung Biologics Reaches Aagreement with Biogen to Acquire Full Ownership of Samsung Bioepis | Pharmtech Focus
GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing | Pharmtech Focus
Samsung Biologics to Add mRNA Vaccine Drug Substance Manufacturing Suite to Expand Portfolio of Services | Pharmtech Focus